Charles L. Daley, MD

Charles L. Daley, MD, from National Jewish Health.

Articles by Charles L. Daley, MD

ALIS Improves Symptoms in Newly Diagnosed MAC Lung Disease, With Charles Daley, MD

May 19th 2026

At ATS 2026, phase 3b ENCORE findings showed amikacin liposome inhalation suspension achieved high culture conversion rates in newly diagnosed MAC lung disease.

Latest Updated Articles

Charles L. Daley, MD

Articles by Charles L. Daley, MD

ALIS Improves Symptoms in Newly Diagnosed MAC Lung Disease, With Charles Daley, MD

Latest Updated Articles

Trending on HCPLive

FDA Expands Exa-Cel Gene Therapy Approval to Children 2 Years and Up With SCD or β-Thalassemia

FDA News Recap: Novel Drug Approvals in Q2 2026

8 Pulmonology Headlines you Missed in Q2 2026

9 Endocrinology Headlines You Missed in Q2 2026

9 Cardiology Headlines You Missed in Q2 2026